Do calcium channel blockers (CCBs) have an effect on blood potassium levels?

Calcium channel blocker antihypertensive drugs generally have no effect on blood potassium levels.

Calcium channel blockers, commonly referred to as "dihydropyridine" antihypertensives, include medications such as amlodipine capsules, felodipine sustained-release tablets, and nifedipine sustained-release tablets. These drugs primarily work by blocking calcium ion influx through cell membranes into cells, thereby reducing the availability of calcium ions necessary for vascular contraction, resulting in lowered blood pressure. They typically do not promote potassium metabolism or interfere with potassium levels, so they generally do not affect blood potassium. Among antihypertensive drugs, diuretics—such as hydrochlorothiazide tablets and furosemide tablets—are more likely to influence blood potassium levels, as they increase urine output and may lead to potassium loss.

Although calcium channel blockers do not affect blood potassium, it is essential to strictly follow medical instructions when taking them. Indiscriminate use may cause side effects such as tachycardia, facial flushing, and constipation, increasing physical discomfort, impairing treatment effectiveness, and leading to poor control of hypertension in patients.